ALFA Finder| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 2.3 |
| Other income | 0.0 | 0.0 | 0.7 |
| Total income | 0.0 | 0.0 | 3.0 |
| Profit before exceptional items & tax | -0.1 | -0.1 | 0.6 |
| Profit before tax | -0.1 | -0.1 | 0.6 |
| Net profit | 0.6 | -0.1 | 0.6 |
| Operating margin | 0.0% | 0.0% | 20.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +0.00% |
|---|
NSE results filing, NSE: VCL. Figures extracted from the filing.
Vaxtex Cotfab Ltd: key numbers
- Share price
- ₹1.55
- Market cap
- ₹28.48 Cr
- Revenue (annual)
- ₹11.17 Cr
- Net profit (annual)
- ₹5.53 Cr
- P/E (TTM)
- 5.4×Sector 46.9×
- Promoter holding
- 0.50%+0.00% QoQ
- FII holding
- 18.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vaxtex Cotfab Ltd
All →Vaxtex Cotfab Annual General Meeting
Vaxtex Cotfab's scrutinizer report confirms shareholders approved appointing a statutory auditor for FY2026-27 to FY2030-31. Votes in favour were 99.99%.
- Execution
- 5 years (FY 2026-27 to FY 2030-31)
Vaxtex Cotfab Legal & Regulatory
Vaxtex Cotfab received an NSE warning letter for a late disclosure of its no-objection application on promoter reclassification. The company says the delay was inadvertent and it will ensure timely filings.
Vaxtex Cotfab Board Meeting Date
Vaxtex Cotfab Limited will hold a board meeting on 13-Nov-2026 to consider unaudited standalone half-yearly results for September 2026. Trading window closure is in effect from 01-Oct-2026.
Vaxtex Cotfab Promoter Reclassification
Vaxtex Cotfab received NSE approval to reclassify Bharti Kailash Gupta, holding 0.40%, from promoter group to public. The change took effect on 5 November 2026.
Vaxtex Cotfab Annual General Meeting
Vaxtex Cotfab Limited issued a Postal Ballot Notice to seek shareholder approval for the appointment of a Statutory Auditor for fiscal years 2026-27 to 2030-31.
Vaxtex Cotfab Board Meeting Outcome
Vaxtex Cotfab's board appointed Garg Agrawal & Agrawal as Statutory Auditor for five years (FY27-31). The board also approved the notice for the upcoming Members' meeting.